Wednesday, August 31, 2016 12:45:20 AM
As far as I know FDA has only labeled cannibidiol as a drug. It is the focus of the major studies. The discussion is not all cannabinoids. If a cannabinoid is marketed as a dietary supplement by a company before it was authorized as a drug for clinical studies, then it may be exempt per FDA warning letters last year.
I will concede that you are right about the chemical process.
I don't see the intentional cross-breeding of plants to enhance certain cannabinoids as "natural". As science furthers in this area, I can see more human tampering with the chemical properties.
You want FDA to regulate like tobacco? Interesting because they can set limits on the amount of nicotine.
It isn't what the FDA determined for themselves. FDA doesn't acto alone in making decisions. They also have advisory boards of independent specialists to help determine a ruling. Only thing they have determined is that they want more information before moving forward with regulation. Perhaps the opiod epidemic is precisely why they are being sensitive to this topic.
Your avoidance of what was addressed by the Leafly article, as well as the specialists in the Weed video concerning the effects on developing brains, proves that you are willing to accept some scientific research that favor your beliefs, but will disregard concerns in other research and dismiss it as "fear mongering".
My posts are solely my opinion unless presented with (or directed to) factual information. All investors are strongly encouraged by myself to do their own due diligence before making an investment decision.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM